Diametric Capital »

Nautilus Biotechnology shares owned by Diametric Capital

Quarter-by-quarter ownership of Nautilus Biotechnology (NAUT) shares owned by Diametric Capital from 13F filings

Historical chart of Diametric Capital investment in Nautilus Biotechnology

Tip: Access up to 7 years of quarterly data

All positions including Nautilus Biotechnology held by Diametric Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Nautilus Biotechnology by Diametric Capital

Quarter filed Position value Share count Share price at filing
2026-03-31 $89k 23k 3.88

More positions owned by Diametric Capital

Precigen (PGEN)
Bitmine Immersion Tecnologie Com New (BMNR)
Janone (ALTS)
Liquidia Corporation Com New (LQDA)
Fulgent Genetics (FLGT)
Golar Lng SHS (GLNG)
Penn National Gaming (PENN)
Wynn Resorts (WYNN)
Brinker International (EAT)
Forgent Power Solutions Com Shs Cl A (FPS)
Asp Isotopes (ASPI)
Telephone & Data Sys Com New (TDS)
Harrow Health (HROW)
Eton Pharmaceuticals (ETON)
A2z Cust2mate Solutions Corp (AZ)

View all positions for Diametric Capital

Top funds holding Nautilus Biotechnology

AH Capital Management
Perceptive Advisors
Cercano Management
Madrona Venture Group
Vanguard Group
Vanguard Capital Management
Hartland & Co
Comprehensive Financial Management
Amazon
Millennium Management
Clarius
_Sentinel Trust Company, LBA______________
Acadian Asset Management
Tikvah Management
Geode Capital Management

View all funds holding Nautilus Biotechnology